DexCom Inc., (DXCM) is a medical device company, that focuses on the design, development & commercialization of glucose monitoring systems globally. It comes under Healthcare sector & trades as “DXCM” ticker at Nasdaq.
The DXCM favors double correction in weekly from November-2021 high discussed in last article few months ago. It favors weakness started from 2.17.2025 high & expect downside into $44.11 or lower.
DXCM – Elliott Wave Latest Weekly View:
In weekly, it ended ((I)) impulse at $164.86 high in November-2021 & now correcting in ((II)). Within ((I)), it ended (I) at $25.82 high in September-2015 & (II) at $10.65 low in September-2017. Above there, it placed (III) as extended move at $114.06 high, (IV) at $76.41 low & finally ended (V) at $164.86 high as ((I)). Below November-2021 high, it favors downside in 7 swings pullback & expect short term bounce in 3, 7 or 11 swings to fail below 7.28.2025 high.
DXCM – Elliott Wave View From 3.31.2025:
Within ((II)) pullback, it ended (w) at $66.89 low in May-2022 & (x) connector at $142 high in March-2024. Both the moves are 3 swings. It already showing lower low sequence in ((II)) correction, favoring (y) down. Below (x) high, it ended w at $62.34 low, x at $93.25 high & favor downside in y leg. The y is further subdivided in ((A)) ended at $57.52 low, ((B)) at $89.98 high & favoring downside in ((c)) of y of (y). It expects weakness against July-2025 high to extend downside in to $44.11 – $20.95 area or even lower. The sellers can enter the set up in 3, 7 or 11 swings corrective bounce at extreme area for targeting weekly extreme area.
Source: https://elliottwave-forecast.com/stock-market/dxcm-eyes-deeper-correction-toward-44-1-20-9/